DUBLIN, Oct. 22, 2020 /PRNewswire/ -- Alkermes plc
(Nasdaq: ALKS) will host a conference call and webcast presentation
at 8:00 a.m. ET (12:00 p.m. GMT) on Thursday, Oct. 29, 2020 to discuss the company's
third quarter 2020 financial results. Management will also provide
an update on the company.
The webcast player and accompanying slides may be accessed on
the Investors section of Alkermes' website at www.alkermes.com. The
conference call may be accessed by dialing +1 877 407 2988 for U.S.
callers and +1 201 389 0923 for international callers.
A replay of the conference call will be available from
11:00 a.m. ET (3:00 p.m. GMT) on Thursday, Oct. 29, 2020, through Thursday Nov. 5, 2020, and may be accessed by
visiting Alkermes' website or by dialing +1 877 660 6853 for U.S.
callers and +1 201 612 7415 for international callers. The replay
access code is 13712082.
About Alkermes plc
Alkermes plc is a fully integrated, global biopharmaceutical
company developing innovative medicines in the fields of
neuroscience and oncology. The company has a portfolio of
proprietary commercial products focused on addiction and
schizophrenia, and a pipeline of product candidates in development
for schizophrenia, bipolar I disorder, neurodegenerative disorders
and cancer. Headquartered in Dublin,
Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and
manufacturing facility in Athlone, Ireland; and a manufacturing facility in
Wilmington, Ohio. For more
information, please visit Alkermes' website at
www.alkermes.com.
Alkermes Contact:
Alex Braun
Investor Relations
+1 781 296 8493
Logo -
https://mma.prnewswire.com/media/616416/Alkermes_plc_Logo.jpg